Compare ARQT & TNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARQT | TNK |
|---|---|---|
| Founded | 2016 | 2007 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.5B |
| IPO Year | 2020 | 2007 |
| Metric | ARQT | TNK |
|---|---|---|
| Price | $23.64 | $73.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | $34.00 | ★ $80.00 |
| AVG Volume (30 Days) | ★ 1.7M | 336.5K |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 2.55% |
| EPS Growth | ★ 88.79 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $376,072,000.00 | N/A |
| Revenue This Year | $34.85 | N/A |
| Revenue Next Year | $29.39 | N/A |
| P/E Ratio | ★ N/A | $8.05 |
| Revenue Growth | ★ 91.34 | N/A |
| 52 Week Low | $12.72 | $41.05 |
| 52 Week High | $31.77 | $83.99 |
| Indicator | ARQT | TNK |
|---|---|---|
| Relative Strength Index (RSI) | 61.99 | 46.59 |
| Support Level | $22.41 | $71.94 |
| Resistance Level | $23.87 | $80.64 |
| Average True Range (ATR) | 0.85 | 2.41 |
| MACD | 0.33 | -0.16 |
| Stochastic Oscillator | 90.53 | 36.65 |
Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.
Teekay Tankers Ltd is a provider of marine services to the international oil and natural gas industries and an operator of medium-sized oil tankers. The company operates in two segments: Tankers, which consists of the operation of all of the company's tankers (including the operations from those tankers employed on full service lightering contracts), and the company's U.S. based ship-to-ship support service operations (including its lightering support services provided as part of full service lightering operations); and Marine Services, which consists of operational and maintenance marine services provided to the Australian government, Australian energy companies and other third parties. The company generates the majority of its revenue from the Tankers segment.